Stephanie Stein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephanie Stein has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Christoph Schramm
Department of Medicine I and Martin Zeitz Center for Rare Diseases, European Reference Network on Hepatological Diseases (ERN Rare-Liver), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publications - Dorothee Schwinge
University Medical Center Hamburg-Eppendorf 1 I. Department of Medicine Hamburg
2 shared publications - Tobias Poch
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
2 shared publications Antonella Carambia
Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publicationB Höh
University Medical Center Hamburg Eppendorf
1 shared publication- Fabian Glaser
Technion Center for Structural Biology (TCSB), Technion Human Health Initiative (THHI), Technion–Israel Institute of Technology, Haifa, Israel
1 shared publication
Latest Publications
- 4 January 2021
- Published by Georg Thieme Verlag KG
- Vol. 59 (01) , 4.6
Interleukin-17 enhances the risk for tumor development in chronic sclerosing cholangitis
Background Primary sclerosing cholangitis (PSC) is a chronic inflammatory liver disease, which leads to cirrhosis and increases the risk of hepatobiliary malignancy, e.g. hepatocellular carcinoma (HCC). PSC pathogenesis remains largely unknown, but patients bear increased numbers of IL-17A-producing CD4+ T cells. In this study we investigated the in vivo effect of IL-17 deficiency on inflammation, fibrosis and tumor development in a mouse model of sclerosing cholangitis. Methods We analyzed B6-Mdr2-/- mice, an established mouse model of sclerosing cholangitis, crossed with IL-17 deficient animals at various time points (5, 36 and 66 weeks). Severity of liver fibrosis was determined by serum transaminases and quantification of Sirius red stained liver sections. Gene expression was analyzed by qPCR and flow cytometric analysis of hepatic and splenic lymphocytes was performed. Liver inflammation was quantified using the modified hepatic activity index (mHAI) score. Onset and growth of hepatic tumors was analyzed via small animal MRI scans. Western Blot analysis was performed to quantify Stat3 activation in liver tissue. Results Deficiency in IL-17 significantly reduced liver fibrosis in mice analyzed at 5 weeks of age. In addition, collagen 1A1 levels were significantly decreased and flow cytometric analysis revealed reduced numbers of neutrophils within liver tissue of 5-week-old Mdr2-/- IL17-/-mice, compared to Mdr2-/- mice. Importantly, the observed difference vanished with age resulting in similar fibrosis levels in Mdr2-/- and Mdr2-/- IL-17-/- mice at the age of 36 and 66 weeks. Moreover, mHAI score, expression of collagen 1A1 and serum transaminases were not altered between the two analyzed groups at these time points. However, although the lack of IL-17 did not seem to affect fibrosis with age, we observed an increased HCC progression at the age of 66 weeks in Mdr2-/- IL-17 competent animals. HCC progression was associated with increased pStat3 levels, enhanced proliferation of hepatocytes and increased IL-6 levels in IL-17 competent Mdr2-/- animals. Conclusion Several studies suggest tumor-promoting effects of IL-17 in the development, progression and recurrence of HCC in patients. We here demonstrate that IL-17 itself does not affect fibrosis development but significantly enhances the risk of developing HCC by activation of known pro-tumorigenic pathways. This work should stimulate further research on IL-17 in the setting of chronic inflammation. Publication Date: 04 January 2021 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 January 2021
- Published by Georg Thieme Verlag KG
- Vol. 59 (01) , 4.6
Interleukin-17 enhances the risk for tumor development in chronic sclerosing cholangitis
Background Primary sclerosing cholangitis (PSC) is a chronic inflammatory liver disease, which leads to cirrhosis and increases the risk of hepatobiliary malignancy, e.g. hepatocellular carcinoma (HCC). PSC pathogenesis remains largely unknown, but patients bear increased numbers of IL-17A-producing CD4+ T cells. In this study we investigated the in vivo effect of IL-17 deficiency on inflammation, fibrosis and tumor development in a mouse model of sclerosing cholangitis. Methods We analyzed B6-Mdr2-/- mice, an established mouse model of sclerosing cholangitis, crossed with IL-17 deficient animals at various time points (5, 36 and 66 weeks). Severity of liver fibrosis was determined by serum transaminases and quantification of Sirius red stained liver sections. Gene expression was analyzed by qPCR and flow cytometric analysis of hepatic and splenic lymphocytes was performed. Liver inflammation was quantified using the modified hepatic activity index (mHAI) score. Onset and growth of hepatic tumors was analyzed via small animal MRI scans. Western Blot analysis was performed to quantify Stat3 activation in liver tissue. Results Deficiency in IL-17 significantly reduced liver fibrosis in mice analyzed at 5 weeks of age. In addition, collagen 1A1 levels were significantly decreased and flow cytometric analysis revealed reduced numbers of neutrophils within liver tissue of 5-week-old Mdr2-/- IL17-/-mice, compared to Mdr2-/- mice. Importantly, the observed difference vanished with age resulting in similar fibrosis levels in Mdr2-/- and Mdr2-/- IL-17-/- mice at the age of 36 and 66 weeks. Moreover, mHAI score, expression of collagen 1A1 and serum transaminases were not altered between the two analyzed groups at these time points. However, although the lack of IL-17 did not seem to affect fibrosis with age, we observed an increased HCC progression at the age of 66 weeks in Mdr2-/- IL-17 competent animals. HCC progression was associated with increased pStat3 levels, enhanced proliferation of hepatocytes and increased IL-6 levels in IL-17 competent Mdr2-/- animals. Conclusion Several studies suggest tumor-promoting effects of IL-17 in the development, progression and recurrence of HCC in patients. We here demonstrate that IL-17 itself does not affect fibrosis development but significantly enhances the risk of developing HCC by activation of known pro-tumorigenic pathways. This work should stimulate further research on IL-17 in the setting of chronic inflammation. Publication Date: 04 January 2021 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 13 November 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (4) , 919-930
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression
- 13 November 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (4) , 919-930
Open AccessIL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression
- 1 January 2020
- Published by Arco Editores
- p. 100-108
METODOLOGIA ALTERNATIVA: GINQUÍMICA– RELEMBRANDO LIGAÇÕES QUÍMICAS E GEOMETRIA MOLECULAR
Dessa forma, o projeto Ginquímica realizado teve como objetivo revisar teoricamente os conteúdos ligações químicas e geometria molecular de forma que facilitasse o entendimento de tais conteúdos, estimulando e motivando o aluno. Para tal objetivo propôs uma gincana química e a elaboração de um mapa conceitual do conteúdo abordado, e por fim aplicou-se metodologias alternativas, como o jogo e a gincana.
- 1 January 2020
- Published by Arco Editores
- p. 100-108
METODOLOGIA ALTERNATIVA: GINQUÍMICA– RELEMBRANDO LIGAÇÕES QUÍMICAS E GEOMETRIA MOLECULAR
Dessa forma, o projeto Ginquímica realizado teve como objetivo revisar teoricamente os conteúdos ligações químicas e geometria molecular de forma que facilitasse o entendimento de tais conteúdos, estimulando e motivando o aluno. Para tal objetivo propôs uma gincana química e a elaboração de um mapa conceitual do conteúdo abordado, e por fim aplicou-se metodologias alternativas, como o jogo e a gincana.
- 1 January 2020
- Published by Arco Editores
- p. 86-99
BALANCEAMENTO QUÍMICO: ROLÊ- BALANCÊ APRENDA JOGANDO!
O presente trabalho traz a utilização de um jogo para as aulas de química. Na busca de despertar o interesse dos alunos, o jogo foi desenvolvido pelos acadêmicos do curso de Licenciatura em Química do Instituto Federal de Ciência e Tecnologia de Rondônia – IFRO, campus Ji-Paraná nas aulas de Metodologia do Ensino de Ciências II. O jogo tem como título: Rolê- Balancê, baseado nos conteúdos de: tabela periódica, reações e balanceamento da disciplina de Química, visto que esses conteúdos são complexos e classificados como difíceis pelos jovens e adolescentes do ensino médio.
- 1 January 2020
- Published by Arco Editores
- p. 86-99
BALANCEAMENTO QUÍMICO: ROLÊ- BALANCÊ APRENDA JOGANDO!
O presente trabalho traz a utilização de um jogo para as aulas de química. Na busca de despertar o interesse dos alunos, o jogo foi desenvolvido pelos acadêmicos do curso de Licenciatura em Química do Instituto Federal de Ciência e Tecnologia de Rondônia – IFRO, campus Ji-Paraná nas aulas de Metodologia do Ensino de Ciências II. O jogo tem como título: Rolê- Balancê, baseado nos conteúdos de: tabela periódica, reações e balanceamento da disciplina de Química, visto que esses conteúdos são complexos e classificados como difíceis pelos jovens e adolescentes do ensino médio.